StatSeal Disc
Merit Medical Systems, Inc. · Decision date May 13, 2026
What did the FDA decide?
FDA records K254073 as a 510(k) premarket notification, with a decision dated May 13, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- May 13, 2026
Regulatory record facts
- Identifier
- K254073
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Merit Medical Systems, Inc.
- Product code
- FRO
- Decision code
- SESE
- Decision date
- May 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dressing, Wound, Drug.
- Applicant
- Merit Medical Systems, Inc.
- Product code
- FRO
- FDA device class
- U
FDA decision timeline
K254073 received
Application receipt date recorded by FDA.
K254073 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FRO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Coloplast Corp. | 510(k) clearance | Oct 26, 2026 | FDA | |
| ACTO GmbH | 510(k) clearance | Sep 22, 2026 | FDA | |
| Magic Science Supply, LLC | 510(k) clearance | Sep 11, 2026 | FDA | |
| Beijing Kreate Medical Co., Ltd. | 510(k) clearance | Aug 14, 2026 | FDA | |
| Urgo Medical North America, LLC | 510(k) clearance | Aug 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Merit Medical Systems, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- South Jordan, UT
Sources and methodology
- Original FDA record: K254073
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


